Kraig Biocraft Laboratories, Inc. (KBLB.OB) Announces Substantial Increase in Number of Insertions

QualityStocks would like to highlight Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB). The company has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

In the company’s news yesterday,

Kraig Biocraft Laboratories, Inc. was pleased to announce that during the months of May, June and July the scientific team achieved its previously announced goal to significantly ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. However, the actual number of insertions performed greatly exceeded that goal and the increase was sustained in June and July as well.

“Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period,” stated CEO Kim K. Thompson. “This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.